Popular
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CENo Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD
Katherine Tuttle, MD
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
CME/CESimple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Nutritional Strategies for Inflammatory Balance and Immune Readiness
NutritionEdgeNutritional Strategies for Inflammatory Balance and Immune Readiness
Steve Jackson, PharmD
Cassie Smith, MD
Two Lenses on Migraine: Managing Incomplete Acute Treatment Response
Innovations In MedicineTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
Fallon Schloemer, DO
Susan Hutchinson, MD
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Programs
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD
Raymond Scott Turner, MD, PhD
Dani Cabral, MD
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CECracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Face Value with Modern Aesthetics: Power of Affordable Post-Procedure Skincare
Modern AestheticsFace Value with Modern Aesthetics: Power of Affordable Post-Procedure Skincare
Ted Lain, MD, MBA
Clinical Practice
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
CME/CEMechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart MattersHypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD
Payal Kohli, MD, FACC
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Understanding the Mechanisms Behind Resistant Hypertension
Heart MattersUnderstanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Healthy Aging and Nutrition: A Lifelong Approach
NutritionEdgeHealthy Aging and Nutrition: A Lifelong Approach
Shelina Ramnarine, PhD
AnnAlisa Behling, ND
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
Combatting Challenges & Health Disparities in Colorectal Cancer Care
Project Oncology®Combatting Challenges & Health Disparities in Colorectal Cancer Care
Jacob Sands, MD
Edith Mitchell, MD, MACP, FCPP, FRCP
"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
The Convergence"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
Brian P. McDonough, MD, FAAFP
Michal Nedoszytko, MD
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Ryan Quigley
Samuel Muench, MD
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
CME
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
CME/CEEngaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
Sayna Norouzi, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CEPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Susana Campos, MD, MPH
Robert Coleman, MD, FACOG
Debra Richardson, MD
Chairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
CME/CEChairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
Jose Rubio, MD
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Industry Feature
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Jennifer Caudle, DO, FACOFP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Medical Industry FeatureOvercoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Jennifer Caudle, DO, FACOFP
Gregory McMahon, DO
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS